World's Best Scientists 2026 revealed!
Monique J. Roobol

Monique J. Roobol

D-Index & Metrics

Medicine

D-Index
102
Citations
46628
World Ranking
7557
National Ranking
293

Monique J. Roobol publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Monique J. Roobol sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 820 publications — 88th percentile

88% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Monique J. Roobol D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Monique J. Roobol sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 102 D-Index — 63rd percentile

63% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Monique J. Roobol is affiliated with Erasmus MC in the Netherlands and has a significant body of work in medical research, particularly focused on prostate cancer. Their expertise spans a range of fields within medicine, including pulmonary and respiratory medicine, oncology, surgery, radiology, nuclear medicine, and imaging, as well as economics and econometrics.

The scientist's research primarily addresses topics related to prostate cancer diagnosis and treatment, prostate cancer treatment and research, and related areas such as global cancer incidence and screening, bladder and urothelial cancer treatments, radiomics and machine learning in medical imaging, health systems, economic evaluations, quality of life, and colorectal cancer screening and detection.

Recent notable publications include:

  • An integrative multi-omics analysis to identify candidate DNA methylation biomarkers related to prostate cancer risk (2020, Nature Communications)
  • Prostate-specific Antigen Testing as Part of a Risk-Adapted Early Detection Strategy for Prostate Cancer: European Association of Urology Position and Recommendations for 2021 (2021, European Urology)
  • Serum PSA-based early detection of prostate cancer in Europe and globally: past, present and future (2022, Nature Reviews Urology)
  • Clinically significant prostate cancer detection and segmentation in low-risk patients using a convolutional neural network on multi-parametric MRI (2020, European Radiology)
  • A European Model for an Organised Risk-stratified Early Detection Programme for Prostate Cancer (2021, European Urology Oncology)

Frequent co-authors collaborating with Roobol include:

  • Sebastiaan Remmers
  • Lionne D. F. Venderbos
  • Mieke Van Hemelrijck
  • Anders Bjartell
  • Daan Nieboer

Roobol has published extensively in prominent scientific venues, with significant contributions appearing in:

  • European Urology
  • European Urology Open Science
  • The Journal of Urology
  • British Journal of Urology
  • Prostate Cancer and Prostatic Diseases

Their research integrates multiple disciplinary approaches to advance early detection and risk stratification in prostate cancer, including the application of multi-omics data, personalized screening strategies using prostate-specific antigen testing, and the use of convolutional neural networks for imaging analysis. This interdisciplinary work reflects their engagement with evolving technologies in medical imaging and machine learning as applied to oncology.

Monique J. Roobol's body of work also encompasses health economic evaluations and quality-of-life considerations as part of broader prostate cancer treatment and screening programs, situating their research at the interface of clinical practice, public health policy, and innovation in diagnostic methodologies.

Best Publications

  • Screening and Prostate-Cancer Mortality in a Randomized European Study

    Fritz H. Schröder;Jonas Hugosson;Monique J. Roobol;Stefano Ciatto

  • MRI-Targeted or Standard Biopsy for Prostate-Cancer Diagnosis

    Veeru Kasivisvanathan;Antti S. Rannikko;Marcelo Borghi;Valeria Panebianco

  • Screening and prostate cancer mortality: results of the European Randomised Study of Screening for Prostate Cancer (ERSPC) at 13 years of follow-up

    Fritz H Schröder;Jonas Hugosson;Monique J Roobol;Teuvo L J Tammela

  • Prostate-Cancer Mortality at 11 Years of Follow-up

    Fritz H. Schröder;Jonas Hugosson;Monique J. Roobol;Stefano Ciatto

  • Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci

    Fredrick R. Schumacher;Ali Amin Al Olama;Sonja I. Berndt;Sara Benlloch

  • Magnetic resonance imaging-targeted biopsy may enhance the diagnostic accuracy of significant prostate cancer detection compared to standard transrectal ultrasound-guided biopsy: a systematic review and meta-analysis.

    Ivo G. Schoots;Monique J. Roobol;Daan Nieboer;Chris H. Bangma

  • Reporting and Interpreting Decision Curve Analysis: A Guide for Investigators.

    Ben Van Calster;Ben Van Calster;Laure Wynants;Jan F.M. Verbeek;Jan Y. Verbakel;Jan Y. Verbakel

  • Active Surveillance for Low-Risk Prostate Cancer Worldwide: The PRIAS Study

    Meelan Bul;Xiaoye Zhu;Riccardo Valdagni;Tom Pickles

  • Prostate MRI, with or without MRI‐targeted biopsy, and systematic biopsy for detecting prostate cancer

    Frankâ€Jan H Drost;Daniël F Osses;Daan Nieboer;Ewout W Steyerberg

  • Complication rates and risk factors of 5802 transrectal ultrasound-guided sextant biopsies of the prostate within a population-based screening program

    René Raaijmakers;Wim J Kirkels;Monique J Roobol;Mark F Wildhagen

  • A 16-yr Follow-up of the European Randomized study of Screening for Prostate Cancer

    Jonas Hugosson;Monique J. Roobol;Marianne Månsson;Teuvo L.J. Tammela

  • Quality-of-life effects of prostate-specific antigen screening.

    Eveline A M Heijnsdijk;Elisabeth M Wever;Anssi Auvinen;Jonas Hugosson

  • Infectious complications and hospital admissions after prostate biopsy in a European randomized trial.

    Stacy Loeb;Suzanne van den Heuvel;Xiaoye Zhu;Chris H. Bangma

  • A Decade of Active Surveillance in the PRIAS Study : an Update and Evaluation of the Criteria Used to Recommend a Switch to Active Treatment

    Leonard P. Bokhorst;Riccardo Valdagni;Antti Rannikko;Yoshiyuki Kakehi

  • Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction

    David V. Conti;Burcu F. Darst;Lilit C. Moss;Edward J. Saunders

  • A risk-based strategy improves prostate-specific antigen-driven detection of prostate cancer.

    Monique J. Roobol;Ewout W. Steyerberg;Ries Kranse;Tineke Wolters

  • Prediction of Indolent Prostate Cancer: Validation and Updating of a Prognostic Nomogram

    E.W. Steyerberg;M.J. Roobol;M.W. Kattan;T.H. van der Kwast

  • Outcomes of men with screen-detected prostate cancer eligible for active surveillance who were managed expectantly.

    Roderick C.N. van den Bergh;Stijn Roemeling;Monique J. Roobol;Gunnar Aus

  • Screening for Prostate Cancer Decreases the Risk of Developing Metastatic Disease: Findings from the European Randomized Study of Screening for Prostate Cancer (ERSPC)

    Fritz H. Schröder;Jonas Hugosson;Sigrid Carlsson;Teuvo Tammela

  • Prostate-Specific Antigen (PSA) Isoform p2PSA in Combination with Total PSA and Free PSA Improves Diagnostic Accuracy in Prostate Cancer Detection

    Flip H. Jansen;Ron H.N. van Schaik;Joep Kurstjens;Wolfgang Horninger

Frequent Co-Authors

Chris H. Bangma
Chris H. Bangma Erasmus University Rotterdam
Ewout W. Steyerberg
Ewout W. Steyerberg Leiden University Medical Center
Anssi Auvinen
Anssi Auvinen Tampere University
David E. Neal
David E. Neal University of Cambridge
Teuvo L.J. Tammela
Teuvo L.J. Tammela Tampere University
Marie-Louise Essink-Bot
Marie-Louise Essink-Bot University of Amsterdam
Harry J. de Koning
Harry J. de Koning Erasmus University Rotterdam
Graham G. Giles
Graham G. Giles University of Melbourne
Andrew J. Vickers
Andrew J. Vickers Memorial Sloan Kettering Cancer Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Interested in healthcare, but want a pathway beyond traditional medical degrees? There are several online options that can prepare you for in-demand careers across the health sector. Aspiring healthcare leaders may consider earning the cheapest online healthcare administration degree, which offers a strong foundation in health systems management. This degree can open doors to roles in hospitals, clinics, and other healthcare settings.

If you already hold a bachelor’s degree, advancing with a specialized master's can be a wise move. The masters in healthcare administration cost can vary, but affordable online programs make it accessible to more students aiming for leadership roles.

For nursing professionals, the best online dnp programs offer a flexible way to take your career to the next level as a Doctor of Nursing Practice. Pharmacists interested in advancing their education can pursue accredited online pharm d programs.

Each of these online degrees offers flexibility, career growth, and the ability to earn while you learn, making them appealing alternatives—or complements—to studying traditional medicine in the USA.

Best Scientists Citing Monique J. Roobol

Trending Scientists